1ELEVAN BIO

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Sept 2025 filing date already counts against anyone who files later.

Record

Serial number

99399472

Mark type

Stylized text

Filed

18 Sept 2025

Published for opposition

07 Apr 2026

Attorney of record

Michael A. Geller

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cardiovascular, respiratory, central nervous system, rheumatology diseases, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, hematology, tissue, organ, ocular, and kidney, urology, oncological, and bone diseases; synthetic peptides for pharmaceutical purposes
• Class 035 — Advertising and business services: Mail order pharmacy services; database management services in the field of peptides, clinical trial information, and government regulatory information
• Class 042 — Scientific and technological services: Laboratory services for biomanufacturing peptides; medical research; medical and pharmaceutical research in the field of peptides; scientific and medical research and design services in the field of peptides; information services in the field of pharmaceutical research and peptides

Owner

• 1Elevan Biopharmaceuticals, Inc., Fishers, IN, US

Prosecution history

• 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 11 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 10 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 10 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 10 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 02 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 02 Mar 2026 — NON-FINAL ACTION E-MAILED
• 02 Mar 2026 — NON-FINAL ACTION WRITTEN
• 11 Feb 2026 — ASSIGNED TO EXAMINER
• 10 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 18 Sept 2025 — APPLICATION FILING RECEIPT MAILED
• 18 Sept 2025 — NEW APPLICATION ENTERED